Sangamo Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio3.680.554.629.8718.68
P/B Ratio9.351.161.752.914.44
Price/Tangible Book9.351.162.493.885.55
Price/FCF14.22
Price/OCF12.99
Enterprise Value Ratios
EV/Revenue3.481.835.5413.15
EV/FCF10.01
Profitability & Returns
Return on Equity (ROE)-1.85%-1.36%-0.57%-0.41%-0.26%
Return on Assets (ROA)-0.46%-0.20%-0.20%-0.14%-0.10%
Return on Capital Employed (ROCE)-1.76%-0.97%-0.45%-0.31%-0.16%
Leverage & Solvency Ratios
Debt/Equity1.340.460.150.130.09
Debt/FCF0.27
Liquidity Ratios
Current Ratio1.131.982.693.124.59
Quick Ratio1.021.782.522.994.51
Efficiency Ratios
Asset Turnover0.430.480.170.130.15
Yield & Distribution Ratios
Earnings Yield-0.46%-2.68%-0.37%-0.16%-0.05%
FCF Yield-0.32%-2.55%-0.47%-0.23%0.07%
Buyback Yield-0.16%-0.13%-0.07%-0.08%-0.20%